Title

Upadacitinib in Adults With Moderate-to-Severe Atopic Dermatitis: 16-Week Results From a Randomized, Placebo-Controlled Trial.

Document Type

Journal Article

Publication Date

11-28-2019

Journal

The Journal of Allergy and Clinical Immunology

DOI

10.1016/j.jaci.2019.11.025

Comments

Epub ahead of print

Peer Reviewed

1

Find in your library

Share

COinS